(Q73517239)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

S Tanaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Murakami

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Horikawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Sugiura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Kawashima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Sugita

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopharmacology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

15-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

Binding of the T cell activation monoclonal antibody Ta1 to dipeptidyl peptidase IV.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Serine protease mechanism: structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Functional role of CD26 on human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Binding of adenosine deaminase to the lymphocyte surface via CD26

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Dipeptidylpeptidase IV--inactivation with N-peptidyl-O-aroyl hydroxylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Recent developments in inhibiting cysteine and serine proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

The determination of enzyme inhibitor constants

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Direct association of adenosine deaminase with a T cell activation antigen, CD26

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Involvement of dipeptidyl peptidase IV in an in vivo immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Purification and characterization of an aminopeptidase hydrolyzing glycyl-proline-naphthylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Dipeptidyl Peptidase IV in the Immune System. Effects of Specific Enzyme Inhibitors on Activity of Dipeptidyl Peptidase IV and Proliferation of Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Solution structures of active and inactive forms of the DP IV (CD26) inhibitor Pro-boroPro determined by NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

An active-site mutation (Gly633-->Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Proline specific endo- and exopeptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Separation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900004-0

7 January 2021

10.1016/S0192-0561(97)00004-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226475%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference